Article

World Hepatitis Day Tops SPT Week in Review

Author(s):

Specialty Pharmacy Times Staff

Top articles of the week from Specialty Pharmacy Times.

5. HIV Suppression Maintained After Switch to Dolutegravir Regimen

Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients. Read more…

4. The Role of Pharmacists in the Health Care Ecosystem

The future for pharmacy is very lucrative as they press on for provider status. Read more…

3. HER2-Positive Breast Cancer Market to Increase Substantially

Global market for HER2-positive breast cancer to increase to $9.89 billion in 2025. Read more…

2. Global Fight Against Hepatitis Continues with World Hepatitis Day

World Hepatitis Day brings awareness to the burden of hepatitis, which is a leading cause of death worldwide. Read more…

1. World Hepatitis Day: New WHO Data Reveal Why We Should Care, How Far We Have Come

Approximately 325 million individuals are living with hepatitis worldwide. Read more…

Related Videos
Senior Doctor is examining An Asian patient.
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Related Content
Streptococcus pneumonia bacteria cells.
November 22nd 2024

Decision to Receive Pneumococcal Vaccine Among Older Adults Is Multi-Factorial, Influenced by Multidimensional Interventions

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

CDC Building -- Image credit: Tada Images | stock.adobe.com
November 22nd 2024

Implementing CDC’s Core Elements of Sepsis

Alyssa Christensen, PharmD, BCIDP Yosef Nissim, PharmD, MBA, BCIDP
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Doctor examining a lung radiography - Image credit: Minerva Studio | stock.adobe.com
November 21st 2024

Usage of AI With PET/CT Images Could Detect Impacts of Immunotherapy in Lung Cancer

Kennedy Ferruggia, Assistant Editor
FDA -- Image credit: wladimir1804 | stock.adobe.com
November 21st 2024

FDA Accepts sNDA for Darolutamide With ADT for Patients With mHSPC

Gillian McGovern, Assistant Editor